Leveraging Precision Medicine to Improve Lives, Reduce Healthcare Costs, and Simplify Decision-making

 <br /><br /><br /><br /> <br />Scott Megill, President and CEO at Coriell Life Sciences, a precision medicine company using genetic science and research to improve lives, reduce healthcare costs, and simplify decision-making for its customers joins eHealth Radio and the Health News Channel.<br />Listen to interview with host Eric Michaels & guest Scott Megill discuss the following:<br />Who is Coriell Life Sciences?<br />How does Coriell Life Sciences partner with the healthcare community to deliver paths to better health?<br />What makes Coriell Life Sciences unique?<br />How can individuals benefit from participating in Coriell Life Sciences’ medication safety program?<br />What’s the biggest opportunity for the healthcare ecosystem when it comes to personalized medicine?<br />Medications don’t work for everyone. Nearly one-third of U.S. adults take five or more prescription drugs and, even when taken correctly, they can be dangerous for many. Payers, providers, and patients bear the financial and physical burdens of inappropriate, ineffective drugs. Each year medication errors lead to 128,000 deaths and the costs of medication-associated errors exceed $40 billion in the U.S. alone. The cost of getting medications wrong reverberates through the healthcare service model and echoes back as wasted resources, time, and poor health.<br />For hundreds of medications, successful treatment is directly related to an individual’s DNA. Natural variation in our genetic code can cause the same drug to produce different effects on different people. The science of pharmacogenomics (PGx) can now assist in assessing how each person will respond to medications, however, DNA testing alone is not sufficient. That’s why Coriell Life Sciences (CLS) leverages advanced, proprietary technology to bridge the gap between genetic knowledge and clinical application. Building on six decades of research, CLS developed a cutting-edge bioinformatics solution that interprets pharmacogenomic laboratory results and couples them with traditional